Performance status and body mass index : prognosis impact of their changes in patients with stage III NSCLC
y. hadidene (Ariana, Tunisia), H. Kamoun (Ariana, Tunisia), A. Slim (Ariana, Tunisia), A. Saidani (Ariana, Tunisia), H. Bellali (Ariana, Tunisia), H. Ben Abdelghaffar (Ariana, Tunisia), H. Smadhi (Ariana, Tunisia), D. Greb (Ariana, Tunisia), H. Hela (Ariana, Tunisia), L. Fkih (Ariana, Tunisia), M. Megdiche (Ariana, Tunisia)
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Session: Localised non-small cell lung cancer
Session type: E-poster session
Number: 1639
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
y. hadidene (Ariana, Tunisia), H. Kamoun (Ariana, Tunisia), A. Slim (Ariana, Tunisia), A. Saidani (Ariana, Tunisia), H. Bellali (Ariana, Tunisia), H. Ben Abdelghaffar (Ariana, Tunisia), H. Smadhi (Ariana, Tunisia), D. Greb (Ariana, Tunisia), H. Hela (Ariana, Tunisia), L. Fkih (Ariana, Tunisia), M. Megdiche (Ariana, Tunisia). Performance status and body mass index : prognosis impact of their changes in patients with stage III NSCLC. 1639
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Body mass index in early stage lung cancer – should we be vigilant? Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017
Influence of the body mass index on the survival of COPD patients Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019
Identification of p-stage I NSCLC patients with high risk of recurrence and poor prognosis by tumor marker index (TMI) Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011
Emergency presentation of lung cancer patients via A&E increases the chances of having advanced disease stage and worse performance status Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017
Staging COPD with body mass index and fat free mass index: relations with parameters expressing disease severity Source: Eur Respir J 2006; 28: Suppl. 50, 162s Year: 2006
Influence of body weight and fat mass on pulmonary function and performance status of COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 538s Year: 2003
Symptom control in advanced non-small cell lung cancer (NSCLC): what is the influence of cisplatin-use, age, performance status and duration of chemotherapy? Analysis of a randomized database Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002
Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013
The relation of body mass index to survival and respiratory function in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 717s Year: 2005
Association of weight loss in COPD patients with low body mass index on outcomes Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable Year: 2011
Assessment of relation between BODE index and quality of life, nutritional status, and C-reactive protein in patients with COPD Source: Annual Congress 2007 - Managing COPD in primary care Year: 2007
Impact of poor performance status of the treatment of small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 394s Year: 2001
The effect of nutritional indicators on prognosis of patients with advanced lung cancer Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019
The effect of nutritional support on pulmonary rehabilitation outcomes in COPD patients with low body mass index Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients Year: 2018
The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Influence of gender and age on correlation between body mass index and lung function in COPD Source: Annual Congress 2012 - COPD epidemiology Year: 2012
Attempting tissue diagnosis in performance status 3 and 4 lung cancer patients may not influence treatment or survival Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013
Performance status as predictor factor of quality of life in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004
The diagnostic value of leptin in progression of GOLD III COPD in patients with excessive body weight Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021